Attachment 2 - Pricing V2.xlsx
XLSX spreadsheet 45 KB Posted
- Attached to
- Anatomic Pathology Services at Travis AFB, CA Federal contract opportunity
- Solicitation number
- FA442724R0015
About this file
This document appears to be an attachment titled "Attachment 2 - Pricing V2.xlsx" related to a federal contract opportunity for Anatomic Pathology Services at Travis AFB, CA.
The attachment provides a detailed pricing structure for various laboratory tests and services, including flow cytometry, cytogenetics, anatomic pathology, molecular pathology, NeoTYPE profiles, and liquid biopsy tests. The pricing is broken down by test name, description, estimated annual quantity, and test price, with totals calculated for each period of performance (base year, option year 1, option year 2, and 6-month extension). The contract period of performance spans from September 2024 through February 2028. This attachment appears to be a comprehensive pricing template for the required laboratory services under this solicitation.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| Amendment 1 - Q and A.pdf | ||
| Attachment 1 - PWS.pdf | ||
| Attachment 3 - Instructions to offerors.pdf | ||
| Attachment 6 - WD 2015-5655 (rev 20) 10 May 24.pdf | ||
| Solicitation - FA442724R0015.pdf | ||
| Attachment 4 - Past Performance References.pdf | ||
| Attachment 5 - Past Performance Questionnare.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Base
| FLOW CYTOMETRY | PERIOD OF PERFORMANCE | Estimated Workload | ||||
| Note test prices in column B are required to be filled out for reference in case if services are needed | Note test prices in column L are required to be filled to calculate total per each year/6-month extension | |||||
| Test Name | Test Price | Estimated 1 September 24 - 31 August 25 | Test Description | Annual Quantity | Test Price | Qty*Price |
| TC Flow Cytometry 1st marker | IHC | 120 | $0 | |||
| Additional Markers | ISH | 60 | $0 | |||
| Flow Interpretation (2-8 Markers) | IHC Panels (MMR or Breast Triple, etc) | 36 | $0 | |||
| Flow Interpretation (9-15 Markers) | Special Stain | 24 | $0 | |||
| Flow Interpretation (16+ Markers) | Flow Cytometry with Interpretation | 40 | $0 | |||
| Flow Profile PNH Tech (8) | FISH testing | 20 | $0 | |||
| Flow Profile PNH Global(8) | Cytogenetics Study with Interpretation | 24 | $0 | |||
| Flow Profile DNA Global | Molecular tests (KRAS/BRAF) | 6 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Tech) | Molecular tests (NGS ALK/NTRK) | 6 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Global) | Molecular tests (RAS/RAF Panel) | 6 | $0 | |||
| Head & Neck Tumor Profile | 3 | $0 | ||||
| CYTOGENETICS | Lung Tumor Profile | 15 | $0 | |||
| Gastric Tumor Profile | 1 | $0 | ||||
| Test Name | Test Price | GI Predictive Profile | 1 | $0 | ||
| Chromosome Analysis (Set Up) | Melanoma Profile | 47 | $0 | |||
| Chromosome Analysis (Cell Analysis) | Ovarian Tumor Profile | 3 | $0 | |||
| Chromosome Analysis Interpretation | Pancreas Tumor Profile | 3 | $0 | |||
| Additional Karyotypes | Thyroid Profile | 3 | $0 | |||
| Additional Cells | Lymphoma Profile | 3 | $0 | |||
| Additional Culture | Breast Tumor Profile | 3 | $0 | |||
| No Growth | PD-L1 tests | 24 | $0 | |||
| Bone Marrow Evaluation with full diagnostic morphology consult | 30 | $0 | ||||
| FISH | Lymphoma Consult | 12 | $0 | |||
| Colorectal Cancer Focus Panel | 3 | $0 | ||||
| Test Name | Test Price | InVisionFirst-Lung Liquid Biposy | 1 | $0 | ||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | BRCA1 and BRCA 2 Focus Panel | 5 | $0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | NeoTYPE Discovery Profile for Hematologic Cancer | 1 | $0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | Full Focus Cancer Panle (Germline) | 25 | $0 | |||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 0001 Total | $0 | ||||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | ||||||
| Bladder Cancer FISH Tech (4 probes) - Manual Read | ||||||
| Bladder Cancer FISH Interp. (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Tech (4 probes) - Auto Read | ||||||
| Bladder Cancer FISH Interp (4 Probes) - Auto Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Auto Read |
ANATOMIC PATHOLOGY
| Test Name | Test Price |
| Blood Smear Interp | |
| Bone Marrow Interp | |
| Surgical Pathology | |
| Surgical Pathology Tech | |
| Decalcification | |
| Decalcification Tech | |
| Special Stain | |
| Special Stain Tech | |
| Tissue Special Stain | |
| Tissue Special Stain Tech | |
| CytoChemisty | |
| Cytochemistry Tech | |
| Consult | |
| Professional Consult | |
| Professional Consult Tech | |
| Comprehensive Consult | |
| IHC Qualitative; addn'l stain procedure | |
| IHC Qualitative; addn'l stain procedure Tech | |
| IHC Qualitative; per specimen; initial single antibody stain | |
| IHC Qualitative; per specimen; initial single antibody stain Tech | |
| IHC Qualitative; per specimen; multiplex antibody stain | |
| IHC Qualitative; per specimen; multiplex antibody stain Tech | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | |
| IHC Quantitative | |
| IHC Quantitative Tech | |
| FOLR1, Glo | |
| FOLR1, Tech | |
| IHC Morphometric Analysis, computer assist, Glo | |
| IHC Morphometric Analysis, computer assist, Tech | |
| IHC by ISH | |
| IHC by ISH TC | |
| HPV ISH | |
| HPV ISH, Tech |
MOLECULAR PATHOLOGY
| Test Name | Test Price |
| ABL1 Kinase Domain Mutation Analysis | |
| ALK Mutation Analysis | |
| BCR-ABL1 Standard p210,p190 | |
| Quantitative BCR/ABL, t(9;22) Major (p210) for CML | |
| Quantitative BCR/ABL, t(9;22) Minor (p190) for ALL | |
| BCR-ABL1 Non-Standard p230 | |
| B-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Beta Gene Rearrangement | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| B&T-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| BRAF Mutation Analysis | |
| Brain NGS Fusion Panel | |
| BRCA1/2 Mutation Analysis for Tumors | |
| Breast NGS Fusion Panel | |
| BTK Inhibitor Acquired Resistance Panel | |
| CALR Mutation Analysis | |
| CEBPA Mutation Analysis | |
| KIT (c-KIT) Mutation Analysis | |
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | |
| Colorectal NGS Fusion Panel | |
| CSF3R Mutation Analysis | |
| CXCR4 Mutation Analysis | |
| EGFR Mutation Analysis | |
| Ewing Sarcoma NGS Fusion Panel | |
| FLT3 (ITD & IKD) Mutation Analysis | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 by PCR | |
| HPV DNA Tissue Testing | |
| IDH1/IDH2 Mutation Analysis by PCR | |
| IgH Clonality by NGS | |
| IgVH Mutation Analysis | |
| inv(16), CBFB-MYH11 Translocation | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| JAK2 V617F with reflex to EXON 12-13 Mutation Analysis | |
| KRAS Mutation Analysis | |
| Lung Complete NGS Fusion Panel | |
| Lung Limited NGS Fusion Panel | |
| MET Exon 14 Deletion Analysis | |
| MGMT Promoter Methylation Analysis | |
| Microsatellite Instability (MSI) by PCR | |
| MLH1 Promoter Methylation Analysis | |
| MPL Mutation Analysis | |
| MPN JAK2 V617F with Sequential Reflex to JAK2 Exon 12-13, CALR, and MPL | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| CALR Mutation Analysis | |
| MPL Mutation Analysis | |
| MYD88 Mutation Analysis | |
| NTRK NGS Fusion Panel | |
| NTRK & RET NGS Fusion Panel | |
| Non-Ewing Sarcoma NGS Fusion Panel | |
| NOTCH1 Mutation Analysis | |
| NPM1 MRD Analysis | |
| NPM1 Mutation Analysis | |
| NRAS Mutation Analysis | |
| PDGFRa Mutation Analysis | |
| PIK3CA LDT Mutation Analysis by Sequencing | |
| PML-RARA Translocation, t(15;17) | |
| Prostate NGS Fusion Panel | |
| Rapid AML Therapeutic Panel | |
| RAS/RAF Panel | |
| Rhabdomyosarcoma NGS Fusion Panel | |
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | |
| Salivary Gland NGS Fusion Panel | |
| Sarcoma Comprehensive NGS Fusion Panel | |
| Targeted Solid Tumor NGS Fusion Panel | |
| TERT Promoter Mutation Analysis | |
| Thyroid NGS Fusion Panel | |
| TP53 Mutation Analysis | |
| Universal Solid Tumor NGS Fusion Panel |
NEOTYPE MOLECULAR
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (GLOBAL)
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (TECHNICAL ONLY)
| Test Name | Test Price |
| NeoTYPE® ALL Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOLAB LIQUID BIOPSY
| Test Name | Test Price |
| InVisionFirst®-Lung Liquid Biopsy | |
| NeoLAB® Solid Tumor Liquid Biopsy |
SPECIMEN HOLD
| Service Name | Service Price |
| Cytogenetics | |
| Culture and Hold | |
| FISH | |
| Direct Harvest and Hold for FISH | |
| Molecular Testing | |
| Freeze and Hold | |
| Extract Nucleic Acid and Hold |
Option Year 1
| FLOW CYTOMETRY | PERIOD OF PERFORMANCE | Estimated Workload | ||||
| Note test prices in column B are required to be filled out for reference in case if services are needed | Note test prices in column L are required to be filled to calculate total per each year/6-month extension | |||||
| Test Name | Test Price | Estimated 1 September 25 - 31 August 26 | Test Description | Annual Quantity | Test Price | Qty*Price |
| TC Flow Cytometry 1st marker | IHC | 120 | $0 | |||
| Additional Markers | ISH | 60 | $0 | |||
| Flow Interpretation (2-8 Markers) | IHC Panels (MMR or Breast Triple, etc) | 36 | $0 | |||
| Flow Interpretation (9-15 Markers) | Special Stain | 24 | $0 | |||
| Flow Interpretation (16+ Markers) | Flow Cytometry with Interpretation | 40 | $0 | |||
| Flow Profile PNH Tech (8) | FISH testing | 20 | $0 | |||
| Flow Profile PNH Global(8) | Cytogenetics Study with Interpretation | 24 | $0 | |||
| Flow Profile DNA Global | Molecular tests (KRAS/BRAF) | 6 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Tech) | Molecular tests (NGS ALK/NTRK) | 6 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Global) | Molecular tests (RAS/RAF Panel) | 6 | $0 | |||
| Head & Neck Tumor Profile | 3 | $0 | ||||
| CYTOGENETICS | Lung Tumor Profile | 15 | $0 | |||
| Gastric Tumor Profile | 1 | $0 | ||||
| Test Name | Test Price | GI Predictive Profile | 1 | $0 | ||
| Chromosome Analysis (Set Up) | Melanoma Profile | 47 | $0 | |||
| Chromosome Analysis (Cell Analysis) | Ovarian Tumor Profile | 3 | $0 | |||
| Chromosome Analysis Interpretation | Pancreas Tumor Profile | 3 | $0 | |||
| Additional Karyotypes | Thyroid Profile | 3 | $0 | |||
| Additional Cells | Lymphoma Profile | 3 | $0 | |||
| Additional Culture | Breast Tumor Profile | 3 | $0 | |||
| No Growth | PD-L1 tests | 24 | $0 | |||
| Bone Marrow Evaluation with full diagnostic morphology consult | 30 | $0 | ||||
| FISH | Lymphoma Consult | 12 | $0 | |||
| Colorectal Cancer Focus Panel | 3 | $0 | ||||
| Test Name | Test Price | InVisionFirst-Lung Liquid Biposy | 1 | $0 | ||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | BRCA1 and BRCA 2 Focus Panel | 5 | $0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | NeoTYPE Discovery Profile for Hematologic Cancer | 1 | $0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | Full Focus Cancer Panle (Germline) | 25 | $0 | |||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 1001 Total | $0 | ||||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | ||||||
| Bladder Cancer FISH Tech (4 probes) - Manual Read | ||||||
| Bladder Cancer FISH Interp. (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Tech (4 probes) - Auto Read | ||||||
| Bladder Cancer FISH Interp (4 Probes) - Auto Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Auto Read |
ANATOMIC PATHOLOGY
| Test Name | Test Price |
| Blood Smear Interp | |
| Bone Marrow Interp | |
| Surgical Pathology | |
| Surgical Pathology Tech | |
| Decalcification | |
| Decalcification Tech | |
| Special Stain | |
| Special Stain Tech | |
| Tissue Special Stain | |
| Tissue Special Stain Tech | |
| CytoChemisty | |
| Cytochemistry Tech | |
| Consult | |
| Professional Consult | |
| Professional Consult Tech | |
| Comprehensive Consult | |
| IHC Qualitative; addn'l stain procedure | |
| IHC Qualitative; addn'l stain procedure Tech | |
| IHC Qualitative; per specimen; initial single antibody stain | |
| IHC Qualitative; per specimen; initial single antibody stain Tech | |
| IHC Qualitative; per specimen; multiplex antibody stain | |
| IHC Qualitative; per specimen; multiplex antibody stain Tech | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | |
| IHC Quantitative | |
| IHC Quantitative Tech | |
| FOLR1, Glo | |
| FOLR1, Tech | |
| IHC Morphometric Analysis, computer assist, Glo | |
| IHC Morphometric Analysis, computer assist, Tech | |
| IHC by ISH | |
| IHC by ISH TC | |
| HPV ISH | |
| HPV ISH, Tech |
MOLECULAR PATHOLOGY
| Test Name | Test Price |
| ABL1 Kinase Domain Mutation Analysis | |
| ALK Mutation Analysis | |
| BCR-ABL1 Standard p210,p190 | |
| Quantitative BCR/ABL, t(9;22) Major (p210) for CML | |
| Quantitative BCR/ABL, t(9;22) Minor (p190) for ALL | |
| BCR-ABL1 Non-Standard p230 | |
| B-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Beta Gene Rearrangement | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| B&T-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| BRAF Mutation Analysis | |
| Brain NGS Fusion Panel | |
| BRCA1/2 Mutation Analysis for Tumors | |
| Breast NGS Fusion Panel | |
| BTK Inhibitor Acquired Resistance Panel | |
| CALR Mutation Analysis | |
| CEBPA Mutation Analysis | |
| KIT (c-KIT) Mutation Analysis | |
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | |
| Colorectal NGS Fusion Panel | |
| CSF3R Mutation Analysis | |
| CXCR4 Mutation Analysis | |
| EGFR Mutation Analysis | |
| Ewing Sarcoma NGS Fusion Panel | |
| FLT3 (ITD & IKD) Mutation Analysis | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 by PCR | |
| HPV DNA Tissue Testing | |
| IDH1/IDH2 Mutation Analysis by PCR | |
| IgH Clonality by NGS | |
| IgVH Mutation Analysis | |
| inv(16), CBFB-MYH11 Translocation | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| JAK2 V617F with reflex to EXON 12-13 Mutation Analysis | |
| KRAS Mutation Analysis | |
| Lung Complete NGS Fusion Panel | |
| Lung Limited NGS Fusion Panel | |
| MET Exon 14 Deletion Analysis | |
| MGMT Promoter Methylation Analysis | |
| Microsatellite Instability (MSI) by PCR | |
| MLH1 Promoter Methylation Analysis | |
| MPL Mutation Analysis | |
| MPN JAK2 V617F with Sequential Reflex to JAK2 Exon 12-13, CALR, and MPL | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| CALR Mutation Analysis | |
| MPL Mutation Analysis | |
| MYD88 Mutation Analysis | |
| NTRK NGS Fusion Panel | |
| NTRK & RET NGS Fusion Panel | |
| Non-Ewing Sarcoma NGS Fusion Panel | |
| NOTCH1 Mutation Analysis | |
| NPM1 MRD Analysis | |
| NPM1 Mutation Analysis | |
| NRAS Mutation Analysis | |
| PDGFRa Mutation Analysis | |
| PIK3CA LDT Mutation Analysis by Sequencing | |
| PML-RARA Translocation, t(15;17) | |
| Prostate NGS Fusion Panel | |
| Rapid AML Therapeutic Panel | |
| RAS/RAF Panel | |
| Rhabdomyosarcoma NGS Fusion Panel | |
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | |
| Salivary Gland NGS Fusion Panel | |
| Sarcoma Comprehensive NGS Fusion Panel | |
| Targeted Solid Tumor NGS Fusion Panel | |
| TERT Promoter Mutation Analysis | |
| Thyroid NGS Fusion Panel | |
| TP53 Mutation Analysis | |
| Universal Solid Tumor NGS Fusion Panel |
NEOTYPE MOLECULAR
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (GLOBAL)
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (TECHNICAL ONLY)
| Test Name | Test Price |
| NeoTYPE® ALL Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOLAB LIQUID BIOPSY
| Test Name | Test Price |
| InVisionFirst®-Lung Liquid Biopsy | |
| NeoLAB® Solid Tumor Liquid Biopsy |
SPECIMEN HOLD
| Service Name | Service Price |
| Cytogenetics | |
| Culture and Hold | |
| FISH | |
| Direct Harvest and Hold for FISH | |
| Molecular Testing | |
| Freeze and Hold | |
| Extract Nucleic Acid and Hold |
Option Year 2
| FLOW CYTOMETRY | PERIOD OF PERFORMANCE | Estimated Workload | ||||
| Note test prices in column B are required to be filled out for reference in case if services are needed | Note test prices in column L are required to be filled to calculate total per each year/6-month extension | |||||
| Test Name | Test Price | Estimated 1 September 26 - 31 August 27 | Test Description | Annual Quantity | Test Price | Qty*Price |
| TC Flow Cytometry 1st marker | IHC | 120 | $0 | |||
| Additional Markers | ISH | 60 | $0 | |||
| Flow Interpretation (2-8 Markers) | IHC Panels (MMR or Breast Triple, etc) | 36 | $0 | |||
| Flow Interpretation (9-15 Markers) | Special Stain | 24 | $0 | |||
| Flow Interpretation (16+ Markers) | Flow Cytometry with Interpretation | 40 | $0 | |||
| Flow Profile PNH Tech (8) | FISH testing | 20 | $0 | |||
| Flow Profile PNH Global(8) | Cytogenetics Study with Interpretation | 24 | $0 | |||
| Flow Profile DNA Global | Molecular tests (KRAS/BRAF) | 6 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Tech) | Molecular tests (NGS ALK/NTRK) | 6 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Global) | Molecular tests (RAS/RAF Panel) | 6 | $0 | |||
| Head & Neck Tumor Profile | 3 | $0 | ||||
| CYTOGENETICS | Lung Tumor Profile | 15 | $0 | |||
| Gastric Tumor Profile | 1 | $0 | ||||
| Test Name | Test Price | GI Predictive Profile | 1 | $0 | ||
| Chromosome Analysis (Set Up) | Melanoma Profile | 47 | $0 | |||
| Chromosome Analysis (Cell Analysis) | Ovarian Tumor Profile | 3 | $0 | |||
| Chromosome Analysis Interpretation | Pancreas Tumor Profile | 3 | $0 | |||
| Additional Karyotypes | Thyroid Profile | 3 | $0 | |||
| Additional Cells | Lymphoma Profile | 3 | $0 | |||
| Additional Culture | Breast Tumor Profile | 3 | $0 | |||
| No Growth | PD-L1 tests | 24 | $0 | |||
| Bone Marrow Evaluation with full diagnostic morphology consult | 30 | $0 | ||||
| FISH | Lymphoma Consult | 12 | $0 | |||
| Colorectal Cancer Focus Panel | 3 | $0 | ||||
| Test Name | Test Price | InVisionFirst-Lung Liquid Biposy | 1 | $0 | ||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | BRCA1 and BRCA 2 Focus Panel | 5 | $0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | NeoTYPE Discovery Profile for Hematologic Cancer | 1 | $0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | Full Focus Cancer Panle (Germline) | 25 | $0 | |||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 2001 Total | $0 | ||||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | ||||||
| Bladder Cancer FISH Tech (4 probes) - Manual Read | ||||||
| Bladder Cancer FISH Interp. (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Tech (4 probes) - Auto Read | ||||||
| Bladder Cancer FISH Interp (4 Probes) - Auto Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Auto Read |
ANATOMIC PATHOLOGY
| Test Name | Test Price |
| Blood Smear Interp | |
| Bone Marrow Interp | |
| Surgical Pathology | |
| Surgical Pathology Tech | |
| Decalcification | |
| Decalcification Tech | |
| Special Stain | |
| Special Stain Tech | |
| Tissue Special Stain | |
| Tissue Special Stain Tech | |
| CytoChemisty | |
| Cytochemistry Tech | |
| Consult | |
| Professional Consult | |
| Professional Consult Tech | |
| Comprehensive Consult | |
| IHC Qualitative; addn'l stain procedure | |
| IHC Qualitative; addn'l stain procedure Tech | |
| IHC Qualitative; per specimen; initial single antibody stain | |
| IHC Qualitative; per specimen; initial single antibody stain Tech | |
| IHC Qualitative; per specimen; multiplex antibody stain | |
| IHC Qualitative; per specimen; multiplex antibody stain Tech | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | |
| IHC Quantitative | |
| IHC Quantitative Tech | |
| FOLR1, Glo | |
| FOLR1, Tech | |
| IHC Morphometric Analysis, computer assist, Glo | |
| IHC Morphometric Analysis, computer assist, Tech | |
| IHC by ISH | |
| IHC by ISH TC | |
| HPV ISH | |
| HPV ISH, Tech |
MOLECULAR PATHOLOGY
| Test Name | Test Price |
| ABL1 Kinase Domain Mutation Analysis | |
| ALK Mutation Analysis | |
| BCR-ABL1 Standard p210,p190 | |
| Quantitative BCR/ABL, t(9;22) Major (p210) for CML | |
| Quantitative BCR/ABL, t(9;22) Minor (p190) for ALL | |
| BCR-ABL1 Non-Standard p230 | |
| B-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Beta Gene Rearrangement | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| B&T-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| BRAF Mutation Analysis | |
| Brain NGS Fusion Panel | |
| BRCA1/2 Mutation Analysis for Tumors | |
| Breast NGS Fusion Panel | |
| BTK Inhibitor Acquired Resistance Panel | |
| CALR Mutation Analysis | |
| CEBPA Mutation Analysis | |
| KIT (c-KIT) Mutation Analysis | |
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | |
| Colorectal NGS Fusion Panel | |
| CSF3R Mutation Analysis | |
| CXCR4 Mutation Analysis | |
| EGFR Mutation Analysis | |
| Ewing Sarcoma NGS Fusion Panel | |
| FLT3 (ITD & IKD) Mutation Analysis | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 by PCR | |
| HPV DNA Tissue Testing | |
| IDH1/IDH2 Mutation Analysis by PCR | |
| IgH Clonality by NGS | |
| IgVH Mutation Analysis | |
| inv(16), CBFB-MYH11 Translocation | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| JAK2 V617F with reflex to EXON 12-13 Mutation Analysis | |
| KRAS Mutation Analysis | |
| Lung Complete NGS Fusion Panel | |
| Lung Limited NGS Fusion Panel | |
| MET Exon 14 Deletion Analysis | |
| MGMT Promoter Methylation Analysis | |
| Microsatellite Instability (MSI) by PCR | |
| MLH1 Promoter Methylation Analysis | |
| MPL Mutation Analysis | |
| MPN JAK2 V617F with Sequential Reflex to JAK2 Exon 12-13, CALR, and MPL | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| CALR Mutation Analysis | |
| MPL Mutation Analysis | |
| MYD88 Mutation Analysis | |
| NTRK NGS Fusion Panel | |
| NTRK & RET NGS Fusion Panel | |
| Non-Ewing Sarcoma NGS Fusion Panel | |
| NOTCH1 Mutation Analysis | |
| NPM1 MRD Analysis | |
| NPM1 Mutation Analysis | |
| NRAS Mutation Analysis | |
| PDGFRa Mutation Analysis | |
| PIK3CA LDT Mutation Analysis by Sequencing | |
| PML-RARA Translocation, t(15;17) | |
| Prostate NGS Fusion Panel | |
| Rapid AML Therapeutic Panel | |
| RAS/RAF Panel | |
| Rhabdomyosarcoma NGS Fusion Panel | |
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | |
| Salivary Gland NGS Fusion Panel | |
| Sarcoma Comprehensive NGS Fusion Panel | |
| Targeted Solid Tumor NGS Fusion Panel | |
| TERT Promoter Mutation Analysis | |
| Thyroid NGS Fusion Panel | |
| TP53 Mutation Analysis | |
| Universal Solid Tumor NGS Fusion Panel |
NEOTYPE MOLECULAR
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (GLOBAL)
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (TECHNICAL ONLY)
| Test Name | Test Price |
| NeoTYPE® ALL Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOLAB LIQUID BIOPSY
| Test Name | Test Price |
| InVisionFirst®-Lung Liquid Biopsy | |
| NeoLAB® Solid Tumor Liquid Biopsy |
SPECIMEN HOLD
| Service Name | Service Price |
| Cytogenetics | |
| Culture and Hold | |
| FISH | |
| Direct Harvest and Hold for FISH | |
| Molecular Testing | |
| Freeze and Hold | |
| Extract Nucleic Acid and Hold |
6 Month Ext
| FLOW CYTOMETRY | PERIOD OF PERFORMANCE | Estimated Workload | ||||
| Note test prices in column B are required to be filled out for reference in case if services are needed | Note test prices in column L are required to be filled to calculate total per each year/6-month extension | |||||
| Test Name | Test Price | 1 September 27 - 29 February 28 | Test Description | Annual Quantity | Test Price | Qty*Price |
| TC Flow Cytometry 1st marker | IHC | 60 | $0 | |||
| Additional Markers | ISH | 30 | $0 | |||
| Flow Interpretation (2-8 Markers) | IHC Panels (MMR or Breast Triple, etc) | 18 | $0 | |||
| Flow Interpretation (9-15 Markers) | Special Stain | 12 | $0 | |||
| Flow Interpretation (16+ Markers) | Flow Cytometry with Interpretation | 20 | $0 | |||
| Flow Profile PNH Tech (8) | FISH testing | 10 | $0 | |||
| Flow Profile PNH Global(8) | Cytogenetics Study with Interpretation | 12 | $0 | |||
| Flow Profile DNA Global | Molecular tests (KRAS/BRAF) | 3 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Tech) | Molecular tests (NGS ALK/NTRK) | 3 | $0 | |||
| Extended Leukemia/Lymphoma Panel (Global) | Molecular tests (RAS/RAF Panel) | 3 | $0 | |||
| Head & Neck Tumor Profile | 1 | $0 | ||||
| CYTOGENETICS | Lung Tumor Profile | 7 | $0 | |||
| Gastric Tumor Profile | 1 | $0 | ||||
| Test Name | Test Price | GI Predictive Profile | 1 | $0 | ||
| Chromosome Analysis (Set Up) | Melanoma Profile | 24 | $0 | |||
| Chromosome Analysis (Cell Analysis) | Ovarian Tumor Profile | 1 | $0 | |||
| Chromosome Analysis Interpretation | Pancreas Tumor Profile | 1 | $0 | |||
| Additional Karyotypes | Thyroid Profile | 1 | $0 | |||
| Additional Cells | Lymphoma Profile | 1 | $0 | |||
| Additional Culture | Breast Tumor Profile | 1 | $0 | |||
| No Growth | PD-L1 tests | 12 | $0 | |||
| Bone Marrow Evaluation with full diagnostic morphology consult | 15 | $0 | ||||
| FISH | Lymphoma Consult | 6 | $0 | |||
| Colorectal Cancer Focus Panel | 1 | $0 | ||||
| Test Name | Test Price | InVisionFirst-Lung Liquid Biposy | 1 | $0 | ||
| FISH Manual - Tech Only (Initial Single Probe Staining Procedure) | BRCA1 and BRCA 2 Focus Panel | 3 | $0 | |||
| FISH Manual - Interp (Initial Single Probe Staining Procedure) | NeoTYPE Discovery Profile for Hematologic Cancer | 1 | $0 | |||
| FISH Manual - Global (Initial Single Probe Staining Procedure) | Full Focus Cancer Panle (Germline) | 12 | $0 | |||
| FISH Manual - Tech Only (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Addn'l Single Probe Staining Procedure) | 3001 Total | $0 | ||||
| FISH Manual - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Manual - Tech Only (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Manual - Global (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Initial Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Global (Addn'l Single Probe Staining Procedure) | ||||||
| FISH Auto - Tech (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Interp (Each Multiplex Probe Staining Procedure) | ||||||
| FISH Auto - Global (Each Multiplex Probe Staining Procedure) | ||||||
| Bladder Cancer FISH Tech (4 probes) - Manual Read | ||||||
| Bladder Cancer FISH Interp. (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Manual Read | ||||||
| Bladder Cancer FISH Tech (4 probes) - Auto Read | ||||||
| Bladder Cancer FISH Interp (4 Probes) - Auto Read | ||||||
| Bladder Cancer FISH Global (4 Probes) - Auto Read |
ANATOMIC PATHOLOGY
| Test Name | Test Price |
| Blood Smear Interp | |
| Bone Marrow Interp | |
| Surgical Pathology | |
| Surgical Pathology Tech | |
| Decalcification | |
| Decalcification Tech | |
| Special Stain | |
| Special Stain Tech | |
| Tissue Special Stain | |
| Tissue Special Stain Tech | |
| CytoChemisty | |
| Cytochemistry Tech | |
| Consult | |
| Professional Consult | |
| Professional Consult Tech | |
| Comprehensive Consult | |
| IHC Qualitative; addn'l stain procedure | |
| IHC Qualitative; addn'l stain procedure Tech | |
| IHC Qualitative; per specimen; initial single antibody stain | |
| IHC Qualitative; per specimen; initial single antibody stain Tech | |
| IHC Qualitative; per specimen; multiplex antibody stain | |
| IHC Qualitative; per specimen; multiplex antibody stain Tech | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Glo | |
| PD-L1 (KEYTRUDA, OPDIVO, TECENTRIQ), Tech | |
| IHC Quantitative | |
| IHC Quantitative Tech | |
| FOLR1, Glo | |
| FOLR1, Tech | |
| IHC Morphometric Analysis, computer assist, Glo | |
| IHC Morphometric Analysis, computer assist, Tech | |
| IHC by ISH | |
| IHC by ISH TC | |
| HPV ISH | |
| HPV ISH, Tech |
MOLECULAR PATHOLOGY
| Test Name | Test Price |
| ABL1 Kinase Domain Mutation Analysis | |
| ALK Mutation Analysis | |
| BCR-ABL1 Standard p210,p190 | |
| Quantitative BCR/ABL, t(9;22) Major (p210) for CML | |
| Quantitative BCR/ABL, t(9;22) Minor (p190) for ALL | |
| BCR-ABL1 Non-Standard p230 | |
| B-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Beta Gene Rearrangement | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| B&T-Cell Gene Rearrangement | |
| B-Cell Gene Rearrangement - IGH | |
| B-Cell Gene Rearrangement - IGK | |
| T-Cell Receptor Gamma Gene Rearrangement | |
| BRAF Mutation Analysis | |
| Brain NGS Fusion Panel | |
| BRCA1/2 Mutation Analysis for Tumors | |
| Breast NGS Fusion Panel | |
| BTK Inhibitor Acquired Resistance Panel | |
| CALR Mutation Analysis | |
| CEBPA Mutation Analysis | |
| KIT (c-KIT) Mutation Analysis | |
| Cholangio/Pancreatic Carcinoma NGS Fusion Panel | |
| Colorectal NGS Fusion Panel | |
| CSF3R Mutation Analysis | |
| CXCR4 Mutation Analysis | |
| EGFR Mutation Analysis | |
| Ewing Sarcoma NGS Fusion Panel | |
| FLT3 (ITD & IKD) Mutation Analysis | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 (incl D385) Mutation Analysis (Bi-directional Seq & Fragment Length) | |
| FLT3 by PCR | |
| HPV DNA Tissue Testing | |
| IDH1/IDH2 Mutation Analysis by PCR | |
| IgH Clonality by NGS | |
| IgVH Mutation Analysis | |
| inv(16), CBFB-MYH11 Translocation | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| JAK2 V617F with reflex to EXON 12-13 Mutation Analysis | |
| KRAS Mutation Analysis | |
| Lung Complete NGS Fusion Panel | |
| Lung Limited NGS Fusion Panel | |
| MET Exon 14 Deletion Analysis | |
| MGMT Promoter Methylation Analysis | |
| Microsatellite Instability (MSI) by PCR | |
| MLH1 Promoter Methylation Analysis | |
| MPL Mutation Analysis | |
| MPN JAK2 V617F with Sequential Reflex to JAK2 Exon 12-13, CALR, and MPL | |
| JAK2 V617F Mutation Analysis | |
| JAK2 EXON 12-13 Mutation Analysis | |
| CALR Mutation Analysis | |
| MPL Mutation Analysis | |
| MYD88 Mutation Analysis | |
| NTRK NGS Fusion Panel | |
| NTRK & RET NGS Fusion Panel | |
| Non-Ewing Sarcoma NGS Fusion Panel | |
| NOTCH1 Mutation Analysis | |
| NPM1 MRD Analysis | |
| NPM1 Mutation Analysis | |
| NRAS Mutation Analysis | |
| PDGFRa Mutation Analysis | |
| PIK3CA LDT Mutation Analysis by Sequencing | |
| PML-RARA Translocation, t(15;17) | |
| Prostate NGS Fusion Panel | |
| Rapid AML Therapeutic Panel | |
| RAS/RAF Panel | |
| Rhabdomyosarcoma NGS Fusion Panel | |
| RUNX1-RUNX1T1 (AML1-ETO) Translocation, t(8;21) | |
| Salivary Gland NGS Fusion Panel | |
| Sarcoma Comprehensive NGS Fusion Panel | |
| Targeted Solid Tumor NGS Fusion Panel | |
| TERT Promoter Mutation Analysis | |
| Thyroid NGS Fusion Panel | |
| TP53 Mutation Analysis | |
| Universal Solid Tumor NGS Fusion Panel |
NEOTYPE MOLECULAR
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (GLOBAL)
| Test Name | Test Price |
| NeoTYPE® AITL/Peripheral T-Cell Lymphoma Profile | |
| NeoTYPE® ALL Profile | |
| NeoTYPE® AML Prognostic Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| Neo Comprehensive - Heme Cancers | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoid Disorders Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® MDS/CMML Profile | |
| Neo Comprehensive – Myeloid Disorders | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| Neo Comprehensive - Solid Tumor | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOTYPE (TECHNICAL ONLY)
| Test Name | Test Price |
| NeoTYPE® ALL Profile | |
| NeoTYPE® CLL Prognostic Profile | |
| NeoTYPE® Follicular Lymphoma Profile | |
| NeoTYPE® Lymphoma Profile | |
| NeoTYPE® Breast Tumor Profile | |
| NeoTYPE® Cervical Tumor Profile | |
| NeoTYPE® Cholangiocarcinoma Profile | |
| NeoTYPE® Colorectal Tumor Profile | |
| NeoTYPE® DNA & RNA - Brain | |
| NeoTYPE® DNA & RNA - Lung | |
| NeoTYPE® Discovery Profile for Solid Tumors | |
| NeoTYPE® Endometrial Tumor Profile | |
| NeoTYPE® Esophageal Tumor Profile | |
| NeoTYPE® Gastric Tumor Profile | |
| NeoTYPE™ Gastric Tumor Profile *If MMR by IHC (88361x4) Not Requested | |
| NeoTYPE® GI Predictive Profile | |
| NeoTYPE® GIST/Soft Tissue Profile | |
| NeoTYPE® Head & Neck Tumor Profile | |
| NeoTYPE® HRR Profile | |
| NeoTYPE® Liposarcoma Fusion Profile | |
| NeoTYPE® Liver/Biliary Tumor Profile | |
| NeoTYPE® Lung Tumor Profile | |
| NeoTYPE® Melanoma Profile | |
| NeoTYPE® Other Solid Tumor Profile | |
| NeoTYPE® Ovarian Tumor Profile | |
| NeoTYPE® Pancreas Tumor Profile | |
| NeoTYPE® Precision Profile for Solid Tumor | |
| NeoTYPE® Thyroid Profile |
NEOLAB LIQUID BIOPSY
| Test Name | Test Price |
| InVisionFirst®-Lung Liquid Biopsy | |
| NeoLAB® Solid Tumor Liquid Biopsy |
SPECIMEN HOLD
| Service Name | Service Price |
| Cytogenetics | |
| Culture and Hold | |
| FISH | |
| Direct Harvest and Hold for FISH | |
| Molecular Testing | |
| Freeze and Hold | |
| Extract Nucleic Acid and Hold |
File details come from the government source that posted it. Updated .